Build a lasting personal brand

SS Innovations International's SSi Mantra Surgical Robot Reaches 14,103 Procedures, 238 Installations Across 12 Countries

By Advos
SS Innovations International reported a 79% increase in procedures using its SSi Mantra surgical robot and a 42% rise in installations, signaling accelerating global adoption of its robotic surgery platform.
SS Innovations International's SSi Mantra Surgical Robot Reaches 14,103 Procedures, 238 Installations Across 12 Countries

SS Innovations International (NASDAQ: SSII) announced on September 10 that cumulative procedures performed with its SSi Mantra surgical robotic system have reached 14,103, a 79% increase from 7,885 at the end of 2025. The company, a developer of innovative surgical robotic technologies, also reported that 238 SSi Mantra systems were installed as of September 8, up 42% from 168 at year-end. The installed base now spans 12 countries, following recent launches in Colombia and Sri Lanka and further international expansion.

The growth in procedures and installations underscores the company's expanding global footprint and the increasing adoption of robotic-assisted surgery. Approximately 1,500 physicians have now been trained on the SSi Mantra system, which has been used in a variety of surgical applications. Pediatric applications continue to expand, including a robotic kidney procedure performed on a 45-day-old infant in India using 5-millimeter instruments, demonstrating the system's versatility for delicate procedures.

SS Innovations also reported 188 cumulative robotic telesurgeries as of August 31, alongside long-distance procedures connecting surgeons and patients across countries. This capability could help address surgeon shortages and improve access to specialized care in remote or underserved regions, potentially transforming surgical care delivery globally.

Looking ahead, the company expects FDA review of its 510(k) submission by the end of Q1 2027 and believes EU CE marking for SSi Mantra could be obtained by the end of 2026. These regulatory milestones could open significant new markets and drive further adoption.

For investors and industry observers, the update, originally released via NEWMEDIAWIRE, highlights SS Innovations' rapid commercial progress. The full release is available on Read More, and the latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. As with all forward-looking statements, actual results may differ materially due to various risks and uncertainties.

Advos

Advos

@advos